BackNeurology

Predictive modeling of vocal biomarkers for the diagnosis of Parkinson’s disease

Cognitive NeurodynamicsResearch Authors: Declan Ikechukwu Emegano, Mubarak Taiwo Mustapha, Emeje Paul Isaac, Ilker Ozsahin, Berna Uzun, Dilber Uzun OzsahinAIIM Authors: Ronit Ganguli, Sara ElanchezhianApproved by President Reda RiffiPublication Date: 2/19/2026

Comprehensive Summary

The aim of the study was to find out whether AI could diagnose Parkinson’s disease by recognizing changes in the voice of the patient. A Kaggle dataset of 1,000 samples with 24 features of voice was reduced to 17 significant voice features. Several machine learning algorithms were tested, including Random Forest, SVM, XGB, LightGBM, CatBoost, and HGB. Then, explainable AI techniques such as SHAP, LIME, and partial dependence plots were applied to determine which of the voice features was the most significant. The best-performing model was HGB, which obtained a score of 1.00 for accuracy, precision, recall, and F1-score on the test set, with a confidence interval ranging from 1.00 to 1.00 and a p-value less than 0.001. The explainability analysis showed that jitter- and shimmer-based vocal biomarkers, which shows instability in voice frequency and amplitude, were the strongest contributors to predicting Parkinson’s disease.

Outcomes and Implications

This paper is significant in that it shows the potential of AI in assisting in the early and accessible detection of Parkinson’s disease through simple speech analysis. A major strength of the paper was the use of comparative machine learning and explainable AI techniques. The fact that jitter and shimmer were found to be the most important factors provides this study with biological significance, as it is possible for measurable changes in speech control to occur in Parkinson’s disease. The perfect performance of the top model should be considered in a particular context since the research only utilized one public data set and does not represent a variety of patient populations. This research should be further tested and validated before it is applied in a clinical environment.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.